Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 63Breast Neoplasms 28Neoplasms 5Neoplasm Metastasis 3Leiomyoma 3Cardiovascular Diseases 3Polycystic Ovary Syndrome 2Neoplasms by Site 2Endometrial Neoplasms 2Breast Diseases 2Advanced Breast Cancer 2Stage II Prostate Adenocarcinoma 1Sleep Wake Disorders 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sarcopenia 1Salivary Gland Neoplasms 1Salivary Gland Adenoma, Pleomorphic 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Pelvic Pain 1Ovarian Neoplasms 1Osteoporosis 1Oligometastatic Prostate Carcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Metastatic Neuroendocrine Prostate Cancer 1

Interventions

Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kallmann Syndrome × Gonadotropin-Releasing Hormone × Clear all
NCT00914823 2024-07-31

Kisspeptin Administration in the Adult

Massachusetts General Hospital

Phase 1 Completed
256 enrolled

Hyperprolactinemia, Hypogonadism, Polycystic Ovary Syndrome, Kallmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡